Position in FTRE
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$835,200
+$383,040 QoQ
Shares Held
48,000
0.0% QoQ
Ownership
0.050%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#107
of 327 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FTRE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Allianz SE holds $20,490,193 across 10 Biotechnology names. FTRE ranks #5 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
23,921 | $11,882,277 | |
| 2 | BMRN |
Biomarin Pharmaceutical Inc
|
73,400 | $4,199,948 | |
| 3 | ASND |
Ascendis Pharma A/S
|
5,077 | $1,354,137 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
3,926 | $946,048 | |
| 5 | FTRE |
Fortrea Holdings Inc.
This page
|
48,000 | $835,200 | |
| 6 | BNTX |
BioNTech SE
|
5,380 | $500,609 | |
| 7 | GNTA |
Genenta Science S.p.A.
|
234,050 | $430,652 | |
| 8 | MRNA |
Moderna, Inc.
|
4,326 | $302,949 |
All Filings in FTRE
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $835,200 | 48,000 | Shares | Defined | 2026-08-10 | |
| 2026-03-31 | $452,160 | 48,000 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $828,000 | 48,000 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $404,160 | 48,000 | Shares | Defined | 2025-11-12 | |
| No filing history on record for this holder in this stock. | ||||||